Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
NCT00526721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1482
Last updated 2012-03-20
Summary
To evaluate achievement ratio of treatment target goal in hypercholesterolemia patients with high risk after high dose rosuvastatin(20mg/day) titration
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Hyunah Caroline Choi · AstraZeneca Korea
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly
NCT03715101 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
NCT03217409 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
NCT02859480 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)
NCT00396110 ·Status: COMPLETED
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED
-
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
NCT01414803 ·Status: COMPLETED ·Phase: PHASE4
-
LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
NCT02077257 ·Status: UNKNOWN ·Phase: PHASE4
-
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04829149 ·Status: COMPLETED
-
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT03571087 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
NCT03446261 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
NCT00695539 ·Status: COMPLETED
-
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
NCT00837083 ·Status: COMPLETED
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED
-
High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
NCT03494270 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
NCT03169985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
NCT07084246 ·Status: ACTIVE_NOT_RECRUITING
-
Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers
NCT01831479 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
NCT03949374 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
NCT00427960 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 ·Status: COMPLETED ·Phase: PHASE3
-
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
NCT03474562 ·Status: COMPLETED ·Phase: PHASE4